U.S. Senate Committee on Homeland Security and Governmental Affairs Subcommittee on Regulatory Affairs and Federal Management held a Hearing on Agency Use of Science in the Rulemaking Process to Provide Proposals for Improving Transparency and Accountability
On January 18, 2017, the FDA released draft revised Guidance for Industry (GFI) #187, “Regulation of Intentionally Altered Genomic DNA in Animals,” and requested public comment regarding the regulation of animals with intentionally altered genomic DNA.
The Environmental Protection Agency said Fiat Chrysler violated the Clean Air Act by allegedly installing and failing to disclose software in some 104,000 cars and trucks that alters emissions.
Public Meeting: Synthetic Biology. To assist the U.S. Department of Defense’s Chemical and Biological Defense Program (CBDP), The National Academies of Sciences, Engineering, and Medicine has appointed an ad hoc committee to address the changing nature of the biodefense threat in the age of synthetic biology.
S. 612 Water Infrastructure Improvement for the Nation (WiiN) Act, S.612, with a vote of 78-21 drew a mix of Republications and Democrats on each side. A bill must be passed by both the House and Senate in identical form and then signed by the President to become law.
21st Century Cures Act PASSES Senate 94-5 . More than $192 million in lobbying expenses have been spent on the 21st Century Cures Act and other legislative priorities by 58 pharmaceutical companies, 24 device companies and 26 biotech companies, according to a Kaiser Health News analysis of lobbying data compiled by the Center for Responsive Politics.
All eyes are on the 21st Century Cures Act this week, a bipartisan bill that would reform the current standards and appropriations for biomedical research, provide $1.75 billion annually for the National Institutes of Health (NIH) and $110 million for the Food and Drug Administration (FDA). This bill is one of the most-lobbied health care bills in recent history, with nearly three lobbyists working for its passage or defeat for every lawmaker on Capitol Hill.